Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Science Signaling
|
November 15, 2018
A cytoskeletal anchor connects ischemic mitochondrial fission to myocardial senescence
Michael J Boyer, Satoru Eguchi
Clinical Science (London, England : 1979)
|
October 7, 2018
Novel role for cardiac myocyte-derived β-2 microglobulin in mediating cardiac fibrosis
Michael J Boyer, Satoru Eguchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
Evolving Landscape of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Steven C Kao, Michael J Boyer
Seminars in Oncology
|
February 7, 2003
Pemetrexed: single-agent and combination phase I study overview
Michael J Boyer, Laurent P Rivory, Stephen J Clarke
Journal of Clinical Medicine
|
June 16, 2018
Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
Megan B Barnet, Wendy A Cooper, Michael J Boyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials
Yu Yang Soon, Martin R Stockler, Lisa M Askie, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
June 6, 2018
Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and Microbes
Megan B Barnet, Prunella Blinman, Wendy Cooper, et al.
Journal of Extracellular Vesicles
|
September 18, 2020
Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins
Michael J Boyer, Yayoi Kimura, Tomoko Akiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2010
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
Steven C H Kao, Nick Pavlakis, Rozelle Harvie, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 30, 2016
Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II
Steven J Forrester, Katherine J Elliott, Tatsuo Kawai, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Science Signaling
|
November 15, 2018
A cytoskeletal anchor connects ischemic mitochondrial fission to myocardial senescence
Michael J Boyer, Satoru Eguchi
Clinical Science (London, England : 1979)
|
October 7, 2018
Novel role for cardiac myocyte-derived β-2 microglobulin in mediating cardiac fibrosis
Michael J Boyer, Satoru Eguchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
Evolving Landscape of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Steven C Kao, Michael J Boyer
Seminars in Oncology
|
February 7, 2003
Pemetrexed: single-agent and combination phase I study overview
Michael J Boyer, Laurent P Rivory, Stephen J Clarke
Journal of Clinical Medicine
|
June 16, 2018
Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
Megan B Barnet, Wendy A Cooper, Michael J Boyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials
Yu Yang Soon, Martin R Stockler, Lisa M Askie, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
June 6, 2018
Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and Microbes
Megan B Barnet, Prunella Blinman, Wendy Cooper, et al.
Journal of Extracellular Vesicles
|
September 18, 2020
Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins
Michael J Boyer, Yayoi Kimura, Tomoko Akiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2010
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
Steven C H Kao, Nick Pavlakis, Rozelle Harvie, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 30, 2016
Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II
Steven J Forrester, Katherine J Elliott, Tatsuo Kawai, et al.
Page
of 3